Famous Patents
William F. Semple, a dentist, was awarded the first US Patent on chewing gum in 1869. His recipe contained powdered chalk.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6593480 | Glucocorticoid receptor antagonists for treatment of diabetes Compounds of formula I ##STR1## are useful for treating type II diabetes, obesity, hyperglycemia, inadequate glucose clearance, hyperinsulinemia, hypertriglyceridemia, and high-circulating glucocorticoid levels, preparations of the compounds, composi... | 07/15/2003 |
| 6583180 | Glucocorticoid receptor modulators Compounds of formula (I) ##STR1## or pharmaceutically acceptable salts thereof are novel glucocorticoid receptor modulators and are useful for treating type II diabetes in a mammal.... | 06/24/2003 |
| 6579882 | Cell adhesion-inhibiting antiinflammatory compounds Compounds having Formula I ##STR1## are useful for treating inflammation. Also disclosed are pharmaceutical compositions comprising compounds of Formula I, and methods of inhibiting/treating inflammatory diseases in a mammal.... | 06/17/2003 |
| 6329534 | Glucocorticoid receptor antagonists for treatment of diabetes Compounds of formula I ##STR1## are useful for treating type II diabetes, obesity, hyperglycemia, inadequate glucose clearance, hyperinsulinemia, hypertriglyceridemia, and high-circulating glucocorticoid levels, preparations of the compounds, composi... | 12/11/2001 |
| 6232320 | Cell adhesion-inhibiting antiinflammatory compounds Compounds having Formula I ##STR1## are useful for treating inflammation. Also disclosed are pharmaceutical compositions comprising compounds of Formula I, and methods of inhibiting/treating inflammatory diseases in a mammal.... | 05/15/2001 |
| 5185364 | Aminomethyl-chroman and -thiochroman compounds The present invention includes compounds represented by the formula: ##STR1## wherein X is O or S; R1 and R2 are independently selected from the group consisting of hydrogen, hydroxy, halo, loweralkoxy, thioalkoxy and loweralkyl; or ... | 02/09/1993 |
| 5140039 | Aminomethyl-thiochroman compounds The present invention includes compounds represented by the formula: ##STR1## wherein X is O or S; R1 and R2 are independently selected from the group consisting of hydrogen, hydroxy, halo, loweralkoxy, thioalkoxy and loweralkyl... | 08/18/1992 |
| 5089519 | Aminomethyl-chroman compounds The present invention includes compounds represented by the formula: ##STR1## wherein X is O or S; R1 and R2 are independently selected from the group consisting of hydrogen, hydroxy, halo, loweralkoxy, thioalkoxy and loweralkyl; or ... | 02/18/1992 |
| 4505932 | Method of producing 2 -adrenergic receptor agonist activity A method of producing 댒 -adrenergic receptor agonist activity by contacting an 댒 -adrenergic receptor with an effective amount of a compound of the formula: ##STR1## wherein R1, R2, R3 | 03/19/1985 |
| 4500543 | Substituted 1-aminomethyl-phthalans Disclosed herein are 1-aminomethyl-phthalans represented by the formula ##STR1## wherein R, R1, and R2 are independently selected from hydrogen, hydroxy, loweralkoxy of 1 to 3 carbon atoms, loweralkenyloxy of 1 to 3 carbon atoms... | 02/19/1985 |
| 4473586 | Aminoalkyl dihydronaphthalenes Disclosed herein are 1-aminoalkyl-3,4-dihydronaphthalenes represented by the formula ##STR1## wherein n is 1 or 2; R, R1, and R2 are independently selected from hydrogen, hydroxy, loweralkoxy of 1 to 3 carbon atoms, loweral... | 09/25/1984 |
| 4234594 | Pyrazolyl amino imidazolines as antihypertensive agents Described is a method of treating hypertensive by administering to mammalian patients compounds of the formula ##STR1## wherein R1 and R2 are hydrogen, loweralkyl, lowercycloalkyl, aralkyl, aryl, pyridyl, isoquinolyl, phthalazin... | 11/18/1980 |
| 4226877 | Pyrazoles active in the central nervous system Disclosed are pyrazoles of the formula ##STR1## wherein R1 is hydrogen, lower alkyl, or phenyl, R2 is hydrogen or lower alkyl, R3 is alkoxy or hydroxy, R4 is lower alkyl, and the pharmaceutically acceptable... | 10/07/1980 |
